Literature DB >> 29044730

New Challenges in Psycho-Oncology Research IV: Cognition and cancer: Conceptual and methodological issues and future directions.

Tim A Ahles1, Arti Hurria2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29044730     DOI： 10.1002/pon.4564

Source DB:  PubMed          Journal:  Psychooncology        ISSN： 1057-9249            Impact factor:   3.894


× No keyword cloud information.
  30 in total

1.  Effects of acupuncture versus cognitive behavioral therapy on cognitive function in cancer survivors with insomnia: A secondary analysis of a randomized clinical trial.

Authors:  Kevin T Liou; James C Root; Sheila N Garland; Jamie Green; Yuelin Li; Q Susan Li; Philip W Kantoff; Tim A Ahles; Jun J Mao
Journal:  Cancer       Date:  2020-04-22       Impact factor: 6.860

Review 2.  Embracing the complexity: Older adults with cancer-related cognitive decline-A Young International Society of Geriatric Oncology position paper.

Authors:  Mackenzi Pergolotti; Nicolò Matteo Luca Battisti; Lynne Padgett; Alix G Sleight; Maya Abdallah; Robin Newman; Kathleen Van Dyk; Kelley R Covington; Grant R Williams; Frederiek van den Bos; YaoYao Pollock; Elizabeth A Salerno; Allison Magnuson; Isabella F Gattás-Vernaglia; Tim A Ahles
Journal:  J Geriatr Oncol       Date:  2019-10-14       Impact factor: 3.599

3.  The relationship between diet and cognitive function in adult cancer survivors: a systematic review.

Authors:  Daniel Coro; Amanda Hutchinson; Sophie Dahlenburg; Siobhan Banks; Alison Coates
Journal:  J Cancer Surviv       Date:  2019-08-09       Impact factor: 4.442

4.  Understanding the Time Course of Cancer-Associated Cognitive Decline: Does Impairment Precede Diagnosis?

Authors:  Brent J Small; Heather S L Jim
Journal:  J Natl Cancer Inst       Date:  2020-05-01       Impact factor: 13.506

5.  Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood.

Authors:  Brent J Small; Heather S L Jim; Sarah L Eisel; Paul B Jacobsen; Stacey B Scott
Journal:  Psychooncology       Date:  2019-08-30       Impact factor: 3.894

6.  Neurophysiologic and ophthalmic markers of chemotherapy-related cognitive impairment in patients diagnosed with hematologic cancer: A feasibility study.

Authors:  David E Anderson; Sachin Kedar; Vijaya R Bhatt; Kendra Schmid; Sarah A Holstein; Matthew Rizzo
Journal:  J Neurol Sci       Date:  2019-12-24       Impact factor: 3.181

7.  Computational Modeling of Neuropsychological Test Performance to Disentangle Impaired Cognitive Processes in Cancer Patients.

Authors:  Joost A Agelink van Rentergem; Ivar E Vermeulen; Philippe R Lee Meeuw Kjoe; Sanne B Schagen
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

8.  Risk of cognition alteration and emotional frailty via circulating transcriptome in treatment naïve head and neck squamous cell cancer patients.

Authors:  A M Anusa; Rooban Thavarajah
Journal:  J Oral Biol Craniofac Res       Date:  2019-03-13

9.  Measuring Aging and Identifying Aging Phenotypes in Cancer Survivors.

Authors:  Jennifer L Guida; Tim A Ahles; Daniel Belsky; Judith Campisi; Harvey Jay Cohen; James DeGregori; Rebecca Fuldner; Luigi Ferrucci; Lisa Gallicchio; Leonid Gavrilov; Natalia Gavrilova; Paige A Green; Chamelli Jhappan; Ronald Kohanski; Kevin Krull; Jeanne Mandelblatt; Kirsten K Ness; Ann O'Mara; Nathan Price; Jennifer Schrack; Stephanie Studenski; Olga Theou; Russell P Tracy; Arti Hurria
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

10.  Cognitive function prior to systemic therapy and subsequent well-being in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study.

Authors:  Lindsay C Kobayashi; Harvey Jay Cohen; Wanting Zhai; Xingtao Zhou; Brent J Small; George Luta; Arti Hurria; Judith Carroll; Danielle Tometich; Brenna C McDonald; Deena Graham; Heather S L Jim; Paul Jacobsen; James C Root; Andrew J Saykin; Tim A Ahles; Jeanne Mandelblatt
Journal:  Psychooncology       Date:  2020-03-17       Impact factor: 3.894
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.